Northern Trust
DNA icon

Northern Trust’s Ginkgo Bioworks DNA Stock Holding History

Northern Trust’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
334,178
+20,903
+7% +$174K ﹤0.01% 2966
2025
Q4 		$2.6M Sell
313,275
-12,233
-4% -$132K ﹤0.01% 2841
2025
Q3 		$4.75M Buy
325,508
+6,565
+2% +$78.6K ﹤0.01% 2532
2025
Q2 		$3.59M Buy
318,943
+217,817
+215% +$1.69M ﹤0.01% 2660
2025
Q1 		$576K Buy
101,126
+6,250
+7% +$63.7K ﹤0.01% 3517
2024
Q4 		$932K Buy
94,876
+9,791
+12% +$83.9K ﹤0.01% 3427
2024
Q3 		$693K Sell
85,085
-62,597
-42% -$627K ﹤0.01% 3477
2024
Q2 		$1.97M Sell
147,682
-1,483
-1% -$44.2K ﹤0.01% 2904
2024
Q1 		$6.92M Sell
149,165
-4,477
-3% -$232K ﹤0.01% 2279
2023
Q4 		$10.4M Buy
153,642
+4,892
+3% +$300K ﹤0.01% 2043
2023
Q3 		$10.8M Buy
148,750
+14,716
+11% +$1.18M ﹤0.01% 1952
2023
Q2 		$9.97M Buy
134,034
+23,728
+22% +$1.4M ﹤0.01% 2067
2023
Q1 		$5.87M Buy
110,306
+7,868
+8% +$499K ﹤0.01% 2358
2022
Q4 		$6.92M Buy
102,438
+25,088
+32% +$2.31M ﹤0.01% 2255
2022
Q3 		$9.65M Sell
77,350
-5,831
-7% -$695K ﹤0.01% 1992
2022
Q2 		$7.92M Buy
83,181
+33,257
+67% +$4.06M ﹤0.01% 2202
2022
Q1 		$8.05M Sell
49,924
-1,370
-3% -$267K ﹤0.01% 2285
2021
Q4 		$17.1M Buy
+51,294
New +$24.4M ﹤0.01% 1890

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust's DNA Position: Q1 2026 in Review

Northern Trust increased its Ginkgo Bioworks (DNA) stake by 6.7% in Q1 2026, buying an estimated $174K and bringing the position to 334,178 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2966.

Northern Trust first reported a position in DNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $17.1M in Q4 2021. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Northern Trust held 334,178 shares of Ginkgo Bioworks worth $2.05M as of Q1 2026.
  • Northern Trust bought 20,903 Ginkgo Bioworks shares in Q1 2026, an estimated $174K.
  • Ginkgo Bioworks made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2966 holding.
  • Northern Trust first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 18 quarters since.
  • Northern Trust's Ginkgo Bioworks position peaked at $17.1M in Q4 2021.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.